399 related articles for article (PubMed ID: 34063112)
1. Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse.
Regoni M; Zanetti L; Comai S; Mercatelli D; Novello S; Albanese F; Croci L; Consalez GG; Ciammola A; Valtorta F; Morari M; Sassone J
Biomedicines; 2021 May; 9(5):. PubMed ID: 34063112
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity.
Regoni M; Cattaneo S; Mercatelli D; Novello S; Passoni A; Bagnati R; Davoli E; Croci L; Consalez GG; Albanese F; Zanetti L; Passafaro M; Serratto GM; Di Fonzo A; Valtorta F; Ciammola A; Taverna S; Morari M; Sassone J
Cell Death Dis; 2020 Nov; 11(11):963. PubMed ID: 33173027
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
4. Loss of locus coeruleus neurons and reduced startle in parkin null mice.
Von Coelln R; Thomas B; Savitt JM; Lim KL; Sasaki M; Hess EJ; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10744-9. PubMed ID: 15249681
[TBL] [Abstract][Full Text] [Related]
5. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
6. Vulnerable Parkin Loss-of-Function
Cackovic J; Gutierrez-Luke S; Call GB; Juba A; O'Brien S; Jun CH; Buhlman LM
Front Cell Neurosci; 2018; 12():39. PubMed ID: 29497364
[TBL] [Abstract][Full Text] [Related]
7. Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout.
Giguère N; Delignat-Lavaud B; Herborg F; Voisin A; Li Y; Jacquemet V; Anand-Srivastava M; Gether U; Giros B; Trudeau LÉ
PLoS Genet; 2019 Aug; 15(8):e1008352. PubMed ID: 31449520
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.
Liang CL; Wang TT; Luby-Phelps K; German DC
Exp Neurol; 2007 Feb; 203(2):370-80. PubMed ID: 17010972
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction.
Suda Y; Kuzumaki N; Sone T; Narita M; Tanaka K; Hamada Y; Iwasawa C; Shibasaki M; Maekawa A; Matsuo M; Akamatsu W; Hattori N; Okano H; Narita M
Mol Brain; 2018 Feb; 11(1):6. PubMed ID: 29458391
[TBL] [Abstract][Full Text] [Related]
10. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
Pinto M; Nissanka N; Moraes CT
J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
[No Abstract] [Full Text] [Related]
11. Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP).
Takanashi M; Mochizuki H; Yokomizo K; Hattori N; Mori H; Yamamura Y; Mizuno Y
Parkinsonism Relat Disord; 2001 Oct; 7(4):311-314. PubMed ID: 11344015
[TBL] [Abstract][Full Text] [Related]
12. Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism.
Song L; McMackin M; Nguyen A; Cortopassi G
Neurobiol Dis; 2017 Apr; 100():30-38. PubMed ID: 28042097
[TBL] [Abstract][Full Text] [Related]
13. The synaptic function of parkin.
Sassone J; Serratto G; Valtorta F; Silani V; Passafaro M; Ciammola A
Brain; 2017 Sep; 140(9):2265-2272. PubMed ID: 28335015
[TBL] [Abstract][Full Text] [Related]
14. Abnormal Development of Glutamatergic Synapses Afferent to Dopaminergic Neurons of the Pink1(-/-) Mouse Model of Parkinson's Disease.
Pearlstein E; Michel FJ; Save L; Ferrari DC; Hammond C
Front Cell Neurosci; 2016; 10():168. PubMed ID: 27445695
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
[TBL] [Abstract][Full Text] [Related]
16. Selective increase of in vivo firing frequencies in DA SN neurons after proteasome inhibition in the ventral midbrain.
Subramaniam M; Kern B; Vogel S; Klose V; Schneider G; Roeper J
Eur J Neurosci; 2014 Sep; 40(6):2898-909. PubMed ID: 25059097
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction in Parkinson's disease.
Hu Q; Wang G
Transl Neurodegener; 2016; 5():14. PubMed ID: 27453777
[TBL] [Abstract][Full Text] [Related]
18. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.
Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK
Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743
[TBL] [Abstract][Full Text] [Related]
19. l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
Billings JL; Gordon SL; Rawling T; Doble PA; Bush AI; Adlard PA; Finkelstein DI; Hare DJ
J Neurochem; 2019 Jul; 150(1):88-106. PubMed ID: 30716176
[TBL] [Abstract][Full Text] [Related]
20. Acute dopamine receptor blockade in substantia nigra pars reticulata: a possible model for drug-induced Parkinsonism.
Cáceres-Chávez VA; Hernández-Martínez R; Pérez-Ortega J; Herrera-Valdez MA; Aceves JJ; Galarraga E; Bargas J
J Neurophysiol; 2018 Dec; 120(6):2922-2938. PubMed ID: 30256736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
